Management has repeatedly given the guidance of a revenue of $120 Million and EBITDA margin of 13% to 14%.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025